In the present study, we genotyped two truncating variants of FANCC (p.R185X and p.R548X) using the Oncoarray (see Methods) in 64,760 female breast cancer cases and 49,793 female population controls of European descent. This evidence concerns the gene FANCC and breast carcinoma.